UBS Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Sell |
841,246
-626,994
| -43% | -$12.8M | ﹤0.01% | 1994 |
|
|
2025
Q1 | $26.6M | Buy |
1,468,240
+1,078,443
| +277% | +$19.6M | ﹤0.01% | 1602 |
|
|
2024
Q4 | $9.85M | Buy |
389,797
+223,200
| +134% | +$5.64M | ﹤0.01% | 2349 |
|
|
2024
Q3 | $5.66M | Buy |
166,597
+6,001
| +4% | +$204K | ﹤0.01% | 2169 |
|
|
2024
Q2 | $5.94M | Sell |
160,596
-95,752
| -37% | -$3.54M | ﹤0.01% | 1980 |
|
|
2024
Q1 | $10.8M | Buy |
256,348
+98,256
| +62% | +$4.12M | ﹤0.01% | 1562 |
|
|
2023
Q4 | $6.27M | Buy |
158,092
+136,897
| +646% | +$5.43M | ﹤0.01% | 1803 |
|
|
2023
Q3 | $583K | Buy |
21,195
+20,418
| +2,628% | +$562K | ﹤0.01% | 3500 |
|
|
2023
Q2 | $26.4K | Sell |
777
-60,098
| -99% | -$2.04M | ﹤0.01% | 5688 |
|
|
2023
Q1 | $2.19M | Sell |
60,875
-58,368
| -49% | -$2.1M | ﹤0.01% | 2508 |
|
|
2022
Q4 | $5.31M | Buy |
119,243
+82,315
| +223% | +$3.67M | ﹤0.01% | 1795 |
|
|
2022
Q3 | $1.04M | Sell |
36,928
-37,350
| -50% | -$1.05M | ﹤0.01% | 2828 |
|
|
2022
Q2 | $2M | Sell |
74,278
-86,501
| -54% | -$2.33M | ﹤0.01% | 2389 |
|
|
2022
Q1 | $5.48M | Buy |
160,779
+30,189
| +23% | +$1.03M | ﹤0.01% | 1855 |
|
|
2021
Q4 | $5.05M | Buy |
130,590
+83,264
| +176% | +$3.22M | ﹤0.01% | 2087 |
|
|
2021
Q3 | $2.56M | Buy |
47,326
+27,013
| +133% | +$1.46M | ﹤0.01% | 2574 |
|
|
2021
Q2 | $679K | Sell |
20,313
-34,536
| -63% | -$1.15M | ﹤0.01% | 3537 |
|
|
2021
Q1 | $1.13M | Buy |
54,849
+52,091
| +1,889% | +$1.07M | ﹤0.01% | 3252 |
|
|
2020
Q4 | $48K | Buy |
2,758
+1,188
| +76% | +$20.7K | ﹤0.01% | 5220 |
|
|
2020
Q3 | $23K | Buy |
1,570
+980
| +166% | +$14.4K | ﹤0.01% | 5332 |
|
|
2020
Q2 | $7K | Sell |
590
-307
| -34% | -$3.64K | ﹤0.01% | 6355 |
|
|
2020
Q1 | $1K | Sell |
897
-618
| -41% | -$689 | ﹤0.01% | 6817 |
|
|
2019
Q4 | $3K | Sell |
1,515
-3,232
| -68% | -$6.4K | ﹤0.01% | 6654 |
|
|
2019
Q3 | $10K | Buy |
4,747
+1,246
| +36% | +$2.63K | ﹤0.01% | 6186 |
|
|
2019
Q2 | $10K | Buy |
3,501
+3,300
| +1,642% | +$9.43K | ﹤0.01% | 6179 |
|
|
2019
Q1 | $1K | Sell |
201
-4,345
| -96% | -$21.6K | ﹤0.01% | 6686 |
|
|
2018
Q4 | $14K | Buy |
4,546
+4,340
| +2,107% | +$13.4K | ﹤0.01% | 6107 |
|
|
2018
Q3 | $1K | Sell |
206
-4,188
| -95% | -$20.3K | ﹤0.01% | 6889 |
|
|
2018
Q2 | $33K | Buy |
4,394
+2,072
| +89% | +$15.6K | ﹤0.01% | 5399 |
|
|
2018
Q1 | $81K | Sell |
2,322
-36
| -2% | -$1.26K | ﹤0.01% | 4527 |
|
|
2017
Q4 | $100K | Sell |
2,358
-2,733
| -54% | -$116K | ﹤0.01% | 4416 |
|
|
2017
Q3 | $219K | Buy |
5,091
+708
| +16% | +$30.5K | ﹤0.01% | 3948 |
|
|
2017
Q2 | $162K | Sell |
4,383
-489
| -10% | -$18.1K | ﹤0.01% | 4003 |
|
|
2017
Q1 | $264K | Sell |
4,872
-7,864
| -62% | -$426K | ﹤0.01% | 3664 |
|
|
2016
Q4 | $677K | Buy |
12,736
+2,720
| +27% | +$145K | ﹤0.01% | 3101 |
|
|
2016
Q3 | $607K | Sell |
10,016
-5,573
| -36% | -$338K | ﹤0.01% | 3034 |
|
|
2016
Q2 | $1.03M | Buy |
15,589
+11,054
| +244% | +$728K | ﹤0.01% | 2678 |
|
|
2016
Q1 | $257K | Sell |
4,535
-12,499
| -73% | -$708K | ﹤0.01% | 3617 |
|
|
2015
Q4 | $4.01M | Buy |
17,034
+12,254
| +256% | +$2.88M | ﹤0.01% | 1677 |
|
|
2015
Q3 | $756K | Sell |
4,780
-792
| -14% | -$125K | ﹤0.01% | 2838 |
|
|
2015
Q2 | $2.11M | Buy |
5,572
+247
| +5% | +$93.4K | ﹤0.01% | 2262 |
|
|
2015
Q1 | $2.23M | Buy |
5,325
+1,457
| +38% | +$609K | ﹤0.01% | 2215 |
|
|
2014
Q4 | $1.06M | Buy |
+3,868
| New | +$1.06M | ﹤0.01% | 2695 |
|